Boardroom myths: reconciling prescription and research guidance
- 1 December 2004
- journal article
- Published by Emerald in Handbook of Business Strategy
- Vol. 5 (1), 15-18
- https://doi.org/10.1108/10775730410494044
Abstract
Not since the passage of the Securities and Exchange Commission Act of 1934 have matters of corporate governance received such concentrated attention. The failures of a series of notable US companies, beginning with Enron Corporation, have reignited attention toward effective corporate governance. The single most remarkable governance‐related outcome of the Enron failure is the passage of the Sarbanes‐Oxley Act of 2002. Congress passed this legislation as a means for remedying the types of governance failures that are believed to have significantly contributed to Enron’s downfall.Keywords
This publication has 6 references indexed in Scilit:
- META-ANALYSES OF FINANCIAL PERFORMANCE AND EQUITY: FUSION OR CONFUSION?The Academy of Management Journal, 2003
- Meta-Analyses of Financial Performance and Equity: Fusion or Confusion?The Academy of Management Journal, 2003
- NUMBER OF DIRECTORS AND FINANCIAL PERFORMANCE: A META-ANALYSIS.The Academy of Management Journal, 1999
- On the Measurements of Board Composition: Poor Consistency and a Serious Mismatch of Theory and OperationalizationDecision Sciences, 1999
- Meta-analytic reviews of board composition, leadership structure, and financial performanceStrategic Management Journal, 1998
- Separate, But Not Independent: Board Leadership Structure in Large CorporationsCorporate Governance: An International Review, 1997